Director/PDMR Shareholding (1420Y)
December 16 2010 - 12:27PM
UK Regulatory
TIDMHIK
RNS Number : 1420Y
Hikma Pharmaceuticals Plc
16 December 2010
Hikma Pharmaceuticals PLC - Share Transactions
LONDON, 16 December 2010: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK), in accordance with DTR 3.1.2R and s.793 of the
Companies Act 2006, announces that Mr. Mazen Darwazah, a Director
and Person Discharging Managerial Responsibility has undertaken
transactions in the Company's Ordinary Shares of 10p each. The
transactions took place in London as detailed below.
On 16 December 2010, Mr Darwazah disposed of 291,366 Ordinary
Shares of 10p each, representing 0.15 per cent. of the issued share
capital of the Company, at an average price of 812.5 pence per
Ordinary Share. The primary purpose of this disposal is to fund the
establishment of the Samih Darwazah Center for Innovation
Management and Entrepreneurship at the American University of
Beirut in Lebanon.
The Company was notified of the transaction on 16 December
2010.
Following these transactions Mr. Darwazah holds 695,225 ordinary
shares, representing 0.36 per cent. of the issued share capital of
the Company.
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles +44 20 7399 2760
Company Secretary
Susan Ringdal +44 20 7399 2760
Investor Relations Director
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based principally in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2009, Hikma achieved
revenues of $637 million and profit attributable to shareholders of
$78 million. For news and other information, please visit
www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBRBDDUDBBGGL
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024